Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia.
Journal: Haematologica
Published: November 10, 2025
Hypomethylating agents plus venetoclax versus intensive chemotherapy in acute myeloid leukemia with chromosome 5 and 7 abnormalities.
Journal: Haematologica
Published: August 07, 2025
Strategies for identifying NUP98 rearrangements in adult myeloid neoplasms.
Journal: Haematologica
Published: April 22, 2025
Last Updated: 09/26/2026